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ABSTRACT
Background: Smoking cessation increases several symptoms, some of which appear to
be due to nicotine withdrawal. One possible feature of withdrawal is impulsivity.
Impulsivity is not currently included as a symptom of nicotine withdrawal neither in the
Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) nor in
withdrawal scales. However, a related term, “impatience” is listed in some nicotine
withdrawal scales. (Hughes J. R., Measurements of the Effects of Abstinence from
Tobacco: A Qualitative Review, 2007). Although impatience is not a synonym of
impulsivity, both share the synonym “impetuous”. Therefore, impatience can be
considered a measure of impulsivity. Although some reviews of the effect of smoking
cessation on impatience have occurred, we know of no quantitative review of prospective
studies of whether smoking cessation increases impatience.
Purpose: To evaluate the effect of smoking cessation on impatience as measured by the
Minnesota Nicotine Withdrawal Scale-Revised (MNWS).
Methods: A literature search of MEDLINE (PubMED), EMBASE, and PsychInfo was
conducted. Articles containing relevant keywords were reviewed by two evaluators
independently. To be considered for inclusion in the meta-analysis, studies had to be
prospective studies, had to have pre-cessation impatience measurements, to include at
least overnight abstinence, had to have smoking abstinence biochemically verified, and
had to include effect size as an outcome measure.
Results: All pooled analyses were based on random-effects models. Seven trials met the
selection criteria. The total number of subjects was 426. There was a significant level of
heterogeneity among studies (χ2 = 55.71 (6), p<0.0001) and (I2 = 89%). The summary
mean effect for impatience after tobacco cessation was an increase of .44 on a 0-3 scale
(95% confidence interval [CI], 0.21-0.67) and a p-value<0.0001.
Conclusion: The meta-analysis shows that impulsivity increases post smoking cessation.
These findings imply that smoking cessation may have an effect on decision making.
Additionally higher rates of impulsivity have been associated with smoking relapse.
(Doran, Spring, McChargue, Peradia, & Richmond, 2004). In order to better assist in the
development of individual treatments, a better understanding is needed of how increased
impulsivity influences cognitive behavior and relapse rates. These findings support the
inclusion of impulsivity as a criterion for nicotine withdrawal.
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GENERALIZED META-ANALYSIS AND STATISTICAL ANALYSIS MODELING

Why Perform a Meta-Analysis:
Advantages
Synthesizing studies increases the power to detect a real effect as statistically significant
if it exists. Primary studies may be small and by combining them in a meta-analysis the
precision of the estimated effect is improved. Smaller studies have lower statistical
power to reject the null hypothesis when it is false. For example, several small studies
may not have significant p-values giving the impression they had small effects, in fact
they may have larger effects than larger studies that have reached significance. The
synthesizing of apparently conflicting studies allows for the evaluation of the statistical
significance of the estimated effect. A meta-analysis is not only interested in the
statistically significance of the effect but the magnitude and the direction of that effect
The p-value only indicates that the estimated effect is not zero but tells us nothing about
the magnitude of the effect, which is what is meaningful to researchers and clinicians.
Additionally, a primary study is targeted to a very specific population resulting in an
estimated effect that is limited to that population, whereas, a meta-analysis allows for the
combination of heterogeneous populations to determine a consistency of effects which is
more generalizable. (Borenstien, Hedges, Higgins, & Rothstein, 2009)
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Disadvantages
Meta-analysis has limitations. There have been large randomized treatment studies
performed studying the same question as a meta-analysis with a drastically different
outcome. (LeLorier, Greoire, Benhaddad, Lapierre, & Derderian, 1997) A meta-analysis
is only as good as its individual studies. If one of the large studies used in the metaanalysis was poorly constructed it may have an adverse effect on the estimated effect. A
meta-analysis has several areas of potential bias, including inclusion/exclusion criteria
used to select the studies and publication bias. Another area of possible bias, or at least
another limitation of meta-analysis, is combining findings across studies that are so
heterogeneous that they perhaps should not be combined. In these cases it can be
misleading to present one average effect when maybe there are multiple true effects, none
of which might be similar to the combined effect obtained from the meta-analysis.
(Borenstien, Hedges, Higgins, & Rothstein, 2009)

Generalized Statistical Approach

The generalized statistical analysis follows the approach of Borenstein, Hedges, Higgins,
and Rothstein, which begins with the calculation of the effect size for each study. Next,
the combination of the individual estimates is used to generate a summary effect. Fixedeffects and random-effects models are used to fit the data. A compare and contrast
between these models will be discussed in the following paragraphs.
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Fixed-Effect Model

The purpose of a fixed effect model is to estimate the unknown common effect size, µ
and measure the accuracy of that estimation. To estimate the common effect size,
compute the summary effect which is the weighted mean of each study. Compute the
weighted mean by multiplying each study’s observed effect by its inverse variance.

Consider a model comparing effect sizes

𝑌𝑖 = 𝜇 + 𝜀𝑖
Yi = observed effect size of the ith study.
µ = is the common effect size i.e. the underling population effect size when there is no
sampling error.
εi = the within study sampling error for the ith study.

The observation effect, Yi for each study is comprised of two components: the unknown
common “true” effect µ and the second component is the within study random sample
error εi.
Figure 1 illustrates that the observed effect Yi is assumed to be normally distributed about
the unknown common effect size µ with the width of the curve based on the variance of
the sampling error, σi 2.
3

The common effect size µ is constant for all studies, which means the sampled
population for each study is identical and any differences between studies is attributed to
random sampling error, εi.

Study

True Effect (µ)

Observed Effect (Yi)

Combined

σ1 2
ε1
σ2 2
ε2
σ3 2
ε3

µ
Figure 1 Fixed-Effect Model – True Effects and the Distribution of Sampling Error
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Assumptions about the Fixed-Effects Model

Yi ∼ Ν (µ, σi2), i = 1,.., k
Generally, the use of a fixed-effect model in a meta-analysis is inappropriate.
Homogeneity among studies is essential for proper use of the fixed effects model.
Although the studies in a meta-analysis are chosen because of their similarity to assume
that each study is sampled from identical populations, i.e. same gender, same age, same
race just to name a few characteristics is unrealistic.

Effect Size Significance Testing

In the fixed-effect model the null hypothesis is that there is zero effect in every study.

𝐻0 : 𝜇 = 0
Limitations of the Fixed-Effect Model
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The inferences from a fixed-effects model are restricted to the studies in the model and
do not test whether effect size varies from study to study. Researchers cannot illuminate
if the intervention is impacted by the study sample.

Performing a Fixed-Effect Meta-Analysis

The goal of a fixed-effects meta-analysis is to estimate the common population effect, µ.
Using the observed effects i.e. the collection of (Yi), we estimate the common effect. To
get the most precise estimate, i.e. to minimize the variance, a weighted mean is
computed. Study weights are assigned to minimize the within study variance. A weight
is assigned to each study, with more weight given to larger studies. The weight for a
fixed-effect meta-analysis is
𝑊𝑖 =

1
𝑉𝑌𝑖

where VYi is the estimate of within-study variance, σi2 . The weighted mean (M), which is
referred to as the “summary effect”, is then computed as

k

M =

∑W Y
i =1
k

i i

∑W
i =1
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i

,

the sum of the products WiYi (the observed effect multiplied by the weight) divided by
the sum of the weights.

The variance of the summary effect is estimated as the reciprocal of the weights and the
estimated standard error of the summary effect is the square root of the variance.

VM =

1
k

∑W
i =1

i

SE M = VM

The 95% lower and upper limits for the summary effect are estimated as

LLM = M − 1.96 × SE M
ULM = M + 1.96 × SE M

To test H 0 : µ = 0 namely, that the true effect µ is zero, a two sided Z test is performed.

Z=

M
SE M
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Identifying Heterogeneity: Q Statistic

The Q statistic, also known as the χ2 heterogeneity test, is a method of identifying the
variation of true effect sizes µ from study to study. Heterogeneity of effect sizes is the
variation of the true effect sizes.

In order to extract the between-study variation from the observed variation the following
process is applied.

1. Compute total observed study to study variation.
2. Estimate how much the observed effects would be expected to vary betweenstudies if there were a true common effect.
3. The difference between the observed variation and the expected variation
quantifies the real differences in effect size i.e. heterogeneity.

The Q statistic is used to analyze and partition the total observed variation.

Derivation of the Q statistic

Q is a weighted sum of squares. To compute Q, subtract each of the effect sizes (Yi) from
the mean (summary effect size M), square it, weight this by the inverse-variance (Wi) for
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the study, and then sum these values over all studies to get the weighted sum of squares
(WSS). (Borenstien, Hedges, Higgins, & Rothstein, 2009)

k

Q = ∑ Wi (Yi − M )

2

i =1

For easier computation

k

Q = ∑ Wi Yi 2 −
i =1

 k

 ∑ Wi Yi 
 i =1


2

k

∑W
i =1

i

Expected value of Q

The expected value of Q is based on the assumption that each study shares a common
effect size µ and any variation is due to sampling error within studies. The expected value
of Q is equal to the degrees of freedom (df). (Borenstien, Hedges, Higgins, & Rothstein,
2009)

Expected (Q ) = df = k − 1 ,

where k is equal to the number of studies. When there is no heterogeneity in effect sizes,
Q is distributed as χ2 with k-1 (df).
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The excess variation is computed by the observed WSS (Q) minus the expected WSS
(df). This difference is the excess variation of the true effects attributed to the variation
study to study, namely heterogeneity.

Q − df

Quantifying Heterogeneity: T and I2

Whereas the Q statistic identifies the existence of heterogeneity, T2 and T reflect the
amount of heterogeneity. T2 is an estimate of τ2 the between-studies variance and T is the
standard deviation of the true effects. In a meta-analysis it is important to report the
summary effect and explain the dispersion of true effects (T) similar to a primary study
where the mean and the standard deviation are reported.

To estimate the variance and the standard deviation T2 and T use Q and remove the
dependence on the number of studies returning it to the original metric. (Higgins &
Green, 2011)
To compute T2 and T
1. Take the difference (Q – df ), which is standardized dispersion of the true effects
2. Divide by quantity C which puts the measurement back into original units and
making it an average, rather than a sum of squared deviations
10

Q − df
C

T=
where

k

Q = ∑ Wi Yi 2 −

 k

 ∑ Wi Yi 
 i =1


2

k

∑W

i =1

i =1

i

df = k − 1

where k is the number of studies, and

k

k

C = ∑ Wi −
i =1

∑W
i =1
k

2
i

∑W
i =1

i

T2 is in the same unit measurement (squared) as the effect size and represents the absolute
amount of variation in that scale. (Borenstien, Hedges, Higgins, & Rothstein, 2009)

I2 is a descriptive statistic that is the proportion of the real differences in effect size to the
total variance. The term “real differences” refers to differences in effect size that is not
attributed to random error. To compute I2
11

𝐼2 =

𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒𝐵𝑒𝑡𝑤𝑒𝑒𝑛
𝑄 − 𝑑𝑓
=�
� × 100%
𝑄
𝑉𝑎𝑟𝑖𝑎𝑛𝑐𝑒𝑇𝑜𝑡𝑎𝑙

I2 values of 25%, 50%, and 75% are considered low, moderate, and high proportions of
heterogeneity, respectively.

Random-Effects Model

The purpose of a random-effects model is to estimate the mean distribution of the effect
sizes, µ and measure the accuracy of that estimation. Unlike a fixed-effects model, for a
random-effects model there is no assumption that each study is estimating the same effect
size µ. To estimate the mean effect size compute the summary effect, this is the weighted
mean of each study. Compute the weighted mean by multiplying each study’s observed
effect by its inverse variance. However, the variance in a random-effects model is
calculated differently than a fixed-effects model and will be discussed in the following
paragraphs.

Once again, consider a model comparing effect sizes

𝑌𝑖 = 𝜇 + ς𝑖 + 𝜀𝑖
Yi = observed effect size of the ith study.
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µ = is the mean of the population distribution of effect size.
εi = the within study sampling error for the ith study.
ςi = true effect of studyi .

Figure 2 illustrates the distribution of three studies drawn from the distribution of studies
depicted by the normal curve. The observation effect, Yi for each study is comprised of
two components. The true effect µ plus the random true effect of studyi, ςi, the second
component is the within study random sampling error εi.

Study

True Effect (µ)

Observed Effect (Yi)

Combined

σ12
ε1

ς1
σ22
ς2

ε2

σ32
ε3
ς3

τ2

Figure 2 Random-Effects Distribution
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Assumptions about the Random-Effects Model

εi ∼ Ν (0, σi2),
ςi ∼ Ν (0, τ2),

i = 1,.., k
i = 1,.., k

Random-effects meta-analysis sampling is a two stage process. First, a random sample of
studies is acquired from a larger population of studies whose true effects can be different
for each study. The true effect is sampled from a distribution with mean µ and variance
τ2. In the second stage, a random sample of subjects is selected from a larger population
of subjects. Yi is sampled from a distribution of the true effects and variance σi2.
(Cooper, Hedges, & Valentine, 2009)

Variance (Yi ) = σi2+ τ2
Effect Size Significance Testing

In the random-effect model the null hypothesis is that there is zero average effect across
studies.
Ho: µ = 0
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Limitations of the Random-Effects Model

The studies in the model may be too heterogeneous to combine in a meta-analysis
rendering any summary effect non-informative.

Performing a Random-Effects Meta-Analysis

The goal of the random-effects meta-analysis is to estimate the range of population
effects. In the random-effects model the summary effect is used to estimate the mean
distribution population effect. To get the most precise estimate, i.e. to minimize the
variance a weighted mean is computed. A weight is assigned to each study. This is the
reciprocal of the study’s total variance. Unlike the fixed-effects model, larger studies
are not assigned more relative weight and smaller studies are not assigned less relative
weight because each study in the analysis represents a unique population. (*) denotes
random-effects model. The weight for a random-effects meta-analysis

Wi * =

1
VYi*

Where V*Yi is the sum of the estimate of within-study variance (VYi) and the estimate of
the between study variance (T2).
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V Yi = V Yi + T
*

where,

2

𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝜎 2 = 𝑉𝑌𝑖

𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝜏 2 = 𝑇 2

The weighted mean (M), which is referred to as the “summary effect”, is then computed
as
k

M =
*

∑W
i =1
k

*
i

∑W
i =1

Yi
*

i

the sum of the products WiYi (the observed effect multiplied by the weight) divided by the
sum of the weights.

The variance of the summary effect is estimated as the reciprocal of the weights and the
estimated standard error of the summary effect is the square root of the variance.

VM * =

1
k

∑W
i =1

*
i

SE M * = V M *
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The 95% lower and upper limits for the summary effect are estimated as

LL M * = M * − 1.96 × SE M *

ULM * = M * + 1.96 × SE M *

To test H 0 : µ = 0 namely that the true effect µ is zero a two sided Z test is performed.

Z* =

M*
SE M *

Forest Plot
A Forest Plot is a graphical representation of the meta-analysis results. To illustrate,
suppose a meta-analysis is performed using four studies A, B, C, and D. In Figure 4,
there are four squares with a horizontal line representing the four individual studies in the
analysis. The size of the square is proportional (in area) to that study’s weight in the
analysis. The diamond represents the summary effect from the analysis. The vertical line
centered at zero represents a null effect. The horizontal lines represents the confidence
interval for each study. The length of the line illustrates the precision or imprecision of
the point estimate. If the horizontal line crosses the vertical line then that study has an
insignificant result. Studies C and D cross the vertical line and therefore contains the null
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result. The middle of the diamond is the summary effect and its width is the confidence
interval.
Impact of Intervention
A
B
C
D
Summary Effect

0
Effect Size

Figure 3 Example of a Forest Plot

Publication Bias
Publication bias can be a serious problem in health research and systematic reviews. Not
all studies are published. Published and unpublished studies frequently have different
results. It is accepted knowledge that larger studies and studies with statistically
significant results are more likely to be published than smaller studies and studies with
statistically non-significant results (Cooper, Hedges, & Valentine, 2009). Compounding
this problem is that well designed and conducted research tends to produce more
statistically non-significant results; hence less likely to be published. If published
18

research is a biased sample of all conducted research then the validity of the resulting
inferences will be questionable, usually overestimating the true effect size because the
studies are unrepresentative of the research population. (Sciences)

Identifying Publication Bias: The Funnel Plot
A funnel plot is a graphical method of detecting publication bias. It is a plot of estimates
of effects versus measures of their precision for each of the primary studies in the metaanalysis. It is called the “funnel” plot because studies of smaller size (less precision) will
have a wider distribution of results than studies of larger size, due to a higher variation.
If publication bias is absent you should expect a symmetrical funnel about the true
population effect size where less precise studies should be scattered to either side of the
more precise studies. (Song, Khan, Dinnes, & Sutton, 2002)
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Figure 4 Example of a Symmetrical Funnel Plot

However; if a funnel plot is asymmetrical there may be other explanations other than
publication bias. If a meta-analysis consists of a small number of studies or high
heterogeneity between studies an inaccurate or asymmetrical funnel plot may be
generated.

20

Assessing the Impact of Publication Bias: Fail-Safe N

The objective of the Fail-Safe N method is to determine the number of unpublished
research (k0) with an average null effect of zero that would bring the overall summary
effect to statistical non-significance i.e. p > 0.05. If it is determined that k0 is so large that
it is implausible there is that much unpublished research in existence then we can be
confident that the statistical significance of the observed effects is likely to be true. To
determine if k0 is realistically achievable it should not exceed a calculated tolerance level.
(Cooper, Hedges, & Valentine, 2009) To compute k0 and the appropriate tolerance level

where k is the number of studies

𝑍=

∑𝑘1 𝑍𝑖
√𝑘

∑𝑘1 𝑍𝑖

�𝑘 + 𝑘0

< 𝑍∝⁄2

that is
𝑘0 > −𝑘 +

with a tolerance level
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�∑𝑘1 𝑍𝑖 �
�𝑍∝⁄2 �

2

2

5𝑘 + 10
So k0 ≥ 5k + 10, implies that if “5k + 10” or more studies are un-retrieved with zero
effect, (compared to the published studies used in the research), on average, the metaanalysis would not reach statistical significance at the five percent level of significance.
(Borenstien, Hedges, Higgins, & Rothstein, 2009)
There are several drawbacks to the Fail Safe N method: it does not consider sample size;
it assumes a zero null effect for the unpublished studies, where the average effect may
really be a non-zero effect; and the heterogeneity among studies is not considered, to
name a few. Therefore, this method should be viewed as a useful, simple but rough
method of assessing the impact of publication bias.
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THE META-ANALYSIS OF STUDIES INVESTIGATING THE EFFECT OF
SMOKING CESSATION ON IMPATIENCE
Background and Literature Review

Smoking cessation increases several symptoms, some of which appear to be due to
nicotine withdrawal. (Shiffman, West, & Gilbert, August 2004) One possible feature of
withdrawal is impulsivity.
Impulsivity is a broad concept that has been defined and measured differently by authors.
The most widely included measures are self-reports of the adjective “impulsivity” or high
scores on multi-item scales of impulsivity (Ashare & Hawk Jr., 2012) such as:
Delay discounting which is a measure of the degree to which an individual is driven by
immediate gratiﬁcation vs. the prospect of larger, but delayed rewards in either
hypothetical or real delay scenarios. (Reynolds, Ortengren, Richards, & de Wit, 2006)
Response inhibition, often defined as an inability to inhibit false positive responses on a
vigilance task i.e. the inability to suppress actions that are inappropriate in a given
context and that interfere with goal-driven behavior. (Logan, Schachar, & Tannock,
1997).
Pre-pulse inhibition is the ability of a weak warning stimulus to reduce the impulsive
reaction to a strong stimulus. (Ashare, Hawk, & Mazzullo, 2007)
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Impulsivity is not currently included as a symptom of nicotine withdrawal neither in the
Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR)
[American Psychiatric Association], International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) nor in withdrawal scales. However, a
related term, “impatience” is listed in some nicotine withdrawal scales. (Hughes J. R.,
2007) Although impatience is not a synonym of impulsivity, both share the synonym
“impetuous”. Therefore, impatience can be considered a measure of impulsivity.
Although some reviews of the effect of smoking abstinence on impatience, delay
discounting, and response inhibition have occurred, we know of no quantitative review of
prospective studies of whether smoking cessation increases one of the above measures of
impulsivity. A meta-analysis of literature findings would be useful to strengthen the
evidence of an association between smoking cessation or smoking deprivation and
increased impulsivity.

Methods

The PRISMA statement for reporting systematic reviews and meta-analyses of studies
that evaluate healthcare interventions was used in the reporting of the research
methodology and its results. (Liberati Alessandro, 2009)

24

Definition of Terms
There are several terms in the literature that are used interchangeably to describe the
discontinuation of tobacco: abstinence, cessation, deprivation, quitting, and stopping. For
simplicity and clarity, this research will use the Hughes, 2007 recommended terms:
abstinence, cessation, and quitting referring to smokers who are trying to stop smoking
permanently and use of deprivation to refer to experimenter-instructed temporary
discontinuation of tobacco use in smokers not trying to stop tobacco use permanently.
In addition to withdrawal effects there is another post-cessation phenomenon called offset
effect. The distinction between withdrawal effects and offset effects is that withdrawal
effects are a time limited pattern of symptoms that may increase or decrease. “Whereas,
offset effects are abstinence effects with a unidirectional change from the typical values
of a smoker i.e. the simple termination of the chronic effects of tobacco.” (Hughes J. R.,
p. 128). For example, once a smoker comes out of withdrawal the continuation of a
symptom may be the return to the original state of that individual prior to smoking; and it
is that original state of being that may have led to the need to begin smoking i.e. an
anxious individual may have begun smoking to reduce their anxiety. Therefore, smoking
has a calming effect and reduces anxiety, the discontinuation of smoking may increase
anxiety and “level off “at pre-smoking levels. That “level off” is the offset effect.
Lastly, impatience is the only measure of impulsivity that is included in this metaanalysis.

This is because, as described below, there were an insufficient number of

studies that measured ratings of “impulsiveness,” delay discounting, response inhibition
or pre-pulse inhibition.
25

Initial Eligibility Criteria
Prospective studies of smoking cessation or smoking deprivation that measured selfreported impatience, at least once during smoking and once during abstinence within the
same participants. The cessation could be experimenter or subject-induced. Smokers
could or could not be trying to stop for good. Analyses could be based on all participants
or only those who successfully abstained. Studies in any language and any year were
eligible. Unpublished studies were eligible. Participants had to be current daily smokers
greater than 18 years old. Participants could not have received a treatment. Abstinence
duration must be more than overnight abstinence and abstinence verification less than
two weeks after smoking cessation begins.

Information Sources
A reference librarian independently searched CINAHL, Medline, and PsychInfo.
Authors used supplementary approaches to identify such as hand searching journals, and
checking reference lists. Search terms included “cigarettes, nicotine, smoking, or
tobacco” AND “abstain, abstinence, cease, cessation, quit, or stop,” AND “impulsivity,
response inhibition, delay discounting, restless”, and their stems in the title or abstract or
keywords and MESH terms. All years were included. We added to this, articles already
obtained by authors, and relevant citations in the texts obtained. The total number of
articles examined was 726 (which include overlap across multiple databases).
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Sample Search Strategy
Table 1 Medline Search

Study Selection
The author and rater (MD and JH) independently examined titles to decide which papers
to proceed to reading of their abstracts. This eliminated 639 articles. Kappa for Interrater agreement reviewing titles was 0.83. The raters then independently read abstracts
searching for key study criteria,: abstinence greater than 12 hours, prospective study,
baseline and post abstinence impulsivity measurement, verification of abstinence, and
adult participants who smoked at least ten cigarettes per day to independently decide
which papers to proceed to reading the entire articles Disagreements were resolved by
mutual consent. This eliminated another 59 articles Kappa for inter-rater agreement on
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complete papers to review include was 0.80. .Finally, the raters independently read entire
articles and decided which papers would be included in the meta-analysis (Figure 1).
This eliminated another 19 articles. Kappa for inter-rater agreement for papers to
include in the meta-analysis was 1.00.
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Literature Search
Databases: Medline,CINAHL,
PscyhInfo and John Hughes

Search Results combined (includes overlap
across multiple databases n=726)

Articles screened on basis of title
Excluded (n=639)
Included (n=87)

Articles screened on basis of abstract
Reasons for Exclusions: no impulsivity (n=26)
not prospective study(n=16) Overnight Abstinence(n=17)
Excluded (n=59) Included (n=28)

Articles review and application of inclusion criteria Excluded (n=19, no impulsivity measure)
Included (n=9)

Added 6 new articles
Final selection for review (n=15)

Measured impatience (n=6, and included)
Other measures of impulsivity (n=9, and excluded)

Final included articles for meta-analysis (n=6)

Figure 5 Flow of information through the different phases of the systematic review

After reviewing selected articles (n=9), the authors decided to expand the search criteria
because there were not enough studies in any particular category of impulsivity for a
meta-analysis. The authors reviewed and now included (if appropriate) the following type
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of articles: abstracts that had been excluded for ‘overnight abstinence’, abstracts that
were excluded because they lacked impulsivity measurement but had an “impatience”
measurement. In addition, the raters located an additional 6 articles from the reference
section of reviewed articles.
With these changes, there were still too few studies of self-rated impulsivity, response
inhibition, delay discounting or pre-pulse inhibition that used sufficiently similar
measures to undertake a meta-analysis. However, there were six studies that met the
criteria and used similar measures of impatience. One study included two groups
(pregnant and non-pregnant smokers) which were analyzed separately, so there were a
total of seven pre/post comparisons available for the meta-analysis.

Data Collection Process
A data extraction sheet to code information for the six included studies was created. One
review author extracted the following data from the included studies and the second
author checked the extracted data. Disagreements were resolved by discussion between
the two review authors.
Data Items
Information was extracted from each study on: characteristics of study participants
(including mean age, gender, race, mean Fagerstrom Test for Nicotine Dependence
(FTND) score) trial’s inclusion and exclusion criteria; duration of smoking cessation,
frequency of the Minnesota Nicotine Withdrawal Scale-Revised (MNWS)
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measurements, whether a special population was used, pre/post impatience score, their
change score and its standard error of the mean, and length of follow up.
For four of the seven comparisons, standard deviations for the pre and post impatience
scores were presented but not the standard deviation for the within-subject differences in
impatience. As a result, the standard deviation for the within subject differences was
estimated from the between subject standard deviation and the estimated within subject
correlation (r). (Cooper, Hedges, & Valentine, 2009, pp. 229-230) The meta-analysis
was performed both using r = 0.6 for the studies that did not report the standard deviation
for the change in impatience.

Risk of Bias within Individual Studies
In a meta-analysis to be confident that the reported intervention effects are accurate
depends on the validity of the included studies. To ascertain the validity of eligible
randomized studies the author determined the adequacy of randomization, and
concealment of allocation, blinding of participants and data collectors; and the extent loss
to follow-up using the Cochrane Collaboration’s tool for assessing risk of bias in
randomized trials. (Higgins, Altman, Gotzche, & Juni, 2011)
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Table 2 Cochrane Collaboration’s Summary Assessments

Risk of bias
Low risk of bias

Unclear risk of bias

High risk of bias

Interpretation
Plausible bias
unlikely to seriously
alter the results.
Plausible bias that
raises some doubt
about the results
Plausible bias that
seriously weakens
confidence in the
results.

Within a study
Low risk of bias for all key
domains.
Unclear risk of bias for one or
more key domains.

High risk of bias for one or more
key domains.

Across studies
Most information is
from studies at low risk
of bias.
Most information is
from studies at low or
unclear risk of bias
The proportion of
information from
studies at high risk of
bias is sufficient to
affect the interpretation
of the results

Figure 6 Author’s judgments about each risk of bias item presented as percentages across all included studies.
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Table 3 Risk of Bias Summary: Author’s judgments about each risk of bias item for each included study.
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Characteristics of Included Studies

Table 4 Comparisons’ Characteristics

%Minority

Cigarettes per day

What treatments were used to induce
abstinence 0 = None;
2 = Money; 3 = Other

66%

_

15

0

100%

4%

7

3

54%

_

_

3

36

59%

_

29

3

106

42

52%

3%

29

3

Ussher, Preg

20

29

100%

94%

14

0

Ussher, non-Preg

95

29

100%

94%

15

0

Special Population:
0=No,1=High Impulsivity
Score 2=Psychiatric
Disorder, 3= Pregnant

Fagerstrom Test of
Nicotine
Ddependence

Abstinence
Verified
1=Yes, 0=No

Etter

0

4.6

0

168

0

76%

Heil

3

_

1

120

0

44%

Hughes, 1986

0

_

1

144

1

0%

Hughes, 1991

0

5.8

1

168

1

22%

Study

Sample (N)

Mean Age

Etter

65

37

Heil

27

25

Hughes, 1986

50

38

Hughes, 1991

105

Jorenby

%Female

No. hours
after
Was Placebo used
abstinence during abstinence Percent of subjects dropped out before last
was the first
period?
measure within 2 week period
measure of 1 = yes; 0 = no
impatience

Jorenby

0

6.8

1

168

1

39%

Ussher, Preg

3

5.2

0

24

0

49%

Ussher, non-Preg

0

4.6

0

24

0

49%
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Table 5Study Description and Design
Study
Etter, Jean, et al. 2012

Heil, Sarah, et al. 2006

Hughes, John, et al. 1986

Hughes, John, et al. 1991

Jorenby, Douglas, et. al.
1996

Ussher, Michael, et al.
2012

Description
In an internet-based study, daily smokers were assigned randomly to continue to smoke
for 2 weeks (n=539) or to stop smoking (n=297). Only the latter group was included in the
meta-analysis). Participants answered followed up surveys 1, 3, and 7 days after their
target quit date. The study measured tobacco withdrawal symptoms using Minnesota
Nicotine Withdrawal Scale. Impatience significantly decreased. The authors did not
expect that abstinence would have significantly decreased impatience. (Etter, Ussher, &
Hughes, 2012)
The aim of this study was to characterize nicotine withdrawal and craving in pregnant
cigarette smokers. Participants self-selected into the abstainer or smoker categories. The
authors examined results from the Minnesota Nicotine Withdrawal Scale in abstainers
(n=27 this group was included in the meta-analysis) and smokers (n=21). Participants
attended daily abstinence monitoring sessions during the first five days of the quit
attempt. Impatience significantly increased more in abstainers than smokers. The results
suggest that pregnant smokers generally may have elevated baseline levels of
withdrawal. (Heil, Higgins, Mongeon, Badger, & Bernstein, 2006)
Smokers were randomly assigned to receive placebo gum (n=50 this group was included
in the meta-analysis) or nicotine gum during a double blind study of the effect of nicotine
gum on the self-reported using the Minnesota Nicotine Withdrawal Scale. Smokers were
counseled about smoking cessation for less than ten minutes. Impatience significantly
increased after smoking cessation in the placebo group. (Hughes & Hatsukami, Signs and
Symptoms of Tobacco Withdrawal, 1986)
Smokers were randomly assigned to receive placebo gum (n= 105 this group was included
in the meta-analysis) or nicotine gum (n=210) during a double blind study of the effect of
nicotine gum on the self-reported using the Minnesota Nicotine Withdrawal. The selfreports were collected 1-2 weeks, 1 month, and 6 months. Impatience significantly
increased post tobacco cessation. (Hughes, Gust, Skoog, Keenan, & Fenwick, 1991)
This was a 5 week multi-site, double-blind nicotine vs placebo gum controlled trial.
Participants were randomly assigned to either active (n=105) or placebo treatment gum
(n= 106 this group was included in the meta-analysis). Adjuvant treatment consisted of
group counseling lasting 1 hour. In addition to the pre-quit visit, groups met three times
in each of the two weeks following the quit date, and twice in both the third and fourth
week post quit for a total of 11 sessions. The study examined smoker’s self-reported
withdrawal symptoms using the Minnesota Nicotine Withdrawal Scale. Impatience
significantly increased in the placebo and active group after smoking cessation. (Jorenby,
et al., 1996)
For the meta-analysis the pregnant abstainers (n=20) and the non-pregnant abstainers
(n=95) were analyzed as two separate analyses, Ussher, 2012a and Ussher, 2012b,
respectively. This study compared tobacco withdrawal using the Minnesota Nicotine
Withdrawal Scale in pregnant and non-pregnant smokers that abstained for 24 hours.
Participants were randomized to either abstain from smoking for 24 hours or smoke as
usual. Impatience significantly increased with smoking cessation. (Ussher, Etter, Giatras,
& Coleman, 2012)
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Statistical Analysis and Results
Effect Size Based On Mean in a Pre-Post Design
This analysis used the raw unstandardized mean difference because the reported outcome
for all the included studies used the Minnesota Nicotine Withdrawal Scale-Revised
(MNWS) and performing the analysis directly on the raw mean difference was intuitively
meaningful and the use of the MNWS scale is widespread. This analysis used the 0-3
MNWS scale. Those studies that provided a 0-4 MNWS were converted to the 0-3
MNWS scale along with their associated standard deviations. This analysis used the
average of the post cessation MNWS repeated measurements as a single score.

Effect size was the mean difference between pre and post cessation impatience scores.
The true population means of the pre-post design is µ1 and µ2 and the population mean
difference is defined as
𝜇 = (𝜇2 − 𝜇1 )
The unbiased estimator of µ is Yi the sample mean difference.

For fixed-effect meta-analysis, the effect sizes for each study are fixed and are unknown
constants. In a random-effects meta-analysis, the true effect size for each study is
different and normally distributed and independent.

Yi~ N (µ+ςi, σi2), i = 1,…, k
36

The goal of this analysis was to determine if there is a significant change in the
impatience score post smoking cessation, as well as provide a confidence interval for that
change score. The mean difference with 95% CIs were calculated for the pooled
estimates. A mean difference > 0 indicates that impatience increased and a mean
difference < 0 indicates that impatience decreased. Heterogeneity was assessed by
examining the forest plots of the seven comparisons, by performing the χ2 heterogeneity
test, and I2 statistics. Data management and analysis were carried out in Review Manager
5.2. and verified using excel 2010.
Prior to any statistical analysis the random-effects model was chosen because the subject
populations varied study to study and the timing and number of post cessation impatience
measurements vastly differed among studies (see Table 6). For the sake of analytical
comparison we also performed analysis using the fixed-effects model.

Fixed-Effect Meta-Analysis
The summary common effect for impatience after tobacco cessation was an increase of
0.51 on a 0-3 scale (95% CI [0.44, 0.59]). There was a significant level of heterogeneity
(χ2 = 55.71 (6), p<0.0001) indicating using the random-effects model for this metaanalysis was more appropriate (see Table 6).
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Table 6 Fixed-Effects Meta-Analysis Results and Forest Plot

The summary effect for impatience after tobacco cessation in the random effects model
was an average increase of 0.44 on a 0-3 scale, p < 0.00001 [95% CI [0.22, 0.67].
(Table 7)

Table 7 Random-Effects Meta-Analysis Results and Forest Plot

Six of the seven comparisons showed a significant increase in impatience with smoking
cessation. The remaining comparison Etter, 2012 showed a non-significant decrease in
impatience. There was considerable heterogeneity between studies I2 = 89%. This
heterogeneity was substantially attributed to the Etter, 2012 study. This was the only
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study that showed a decrease in impatience, albeit a statistically insignificant decrease,
([-0.12, 95% CI [-0.32, 0.08]). As a sensitivity analysis, the Etter, 2012 study was
removed from the data and heterogeneity was reassessed on the remaining data with the
following results: (0.58, 95%CI [0.46, 0.69]); T² = 0.01; χ² = 9.38 (5), (p = 0.09);
I² = 47% and Z = 10.02 (p < 0.00001). Removing the Etter, 2012 study increased the
effect size estimate and reduced heterogeneity to a statistically insignificant level while
maintaining a significant summary effect confirming it as a major source of variation.
The confidence interval tells us how confident we can be in the effect size. Ideally, the
narrower the interval the more confident we should be in the effect size estimate. The
confidence interval for the random-effects analysis [0.22, 0.67] was wider than the fixedeffects analysis [0.44, 0.59] because the summary effect is a less precise estimate because
of the increase variation due to heterogeneity. This same information is presented
graphically in Table 7 and Table 8. Each study is represented by a box and bounded by a
confidence interval and the combined results and confidence interval is shown by the
diamond.
Assessing publication bias was addressed using the funnel plot and the fail-safe N
methods. Figure 7 is asymmetric funnel plot and gives the appearance of potential
publication bias; however, with only seven comparisons in this meta-analysis and I2 of
89% an asymmetrical funnel plot is not unexpected regardless of the possibility of
publication bias.
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Effect Size (SE)

FUNNEL PLOT OF RANDOM EFFECTS ANALYSIS

Etter 2012

Mean Difference
Figure 7 Funnel plot of effect size estimates for all individual comparisons in the meta-analysis
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Next, to assess the potential for publication bias to have influenced the results of this
meta-analysis we calculated the ‘fail-safe N’, the number of additional ‘negative’ studies
(studies in which the intervention average effect is zero) that would be needed to increase
the P value for the meta-analysis to above 0.05. To that end, individual z scores were
computed by dividing the effect size by the corresponding standard errors. This lead to
∑zi = 12.49; k0 > -7 + (33.03/1.96)2 leading to k0 ≥ 277. If there were 277 unpublished
studies with the mean null effect of zero than the results of the meta-analysis would be
reversed; However 277 unpublished studies far exceeds the tolerance level of
5k + 10 = 45 and it can be inferred that it is unrealistic to believe there are 277 unretrievable studies therefore; the result of the observed effects were not affected by
publication bias.

Discussion
The meta-analysis revealed that nicotine withdrawal significantly increases impulsivity as
measured by a significant increase of impatience over baseline ratings.
This meta-analysis has several strengths and some limitations that deserve mention. The
strengths include the comprehensive search strategy that improved the likelihood of
identifying all relevant studies. Over 700 citations were searched and 28 articles were
read. An independent parallel process for selecting studies and the extraction of data
reduced the potential for bias. The included studies used a well-established scale to
measure impulsivity. Six of the seven comparisons were randomized trials which would
have reduced the likelihood of systematic error.
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Fail Safe N method suggests the summary effect was not influenced by publication bias
and did not contribute to the asymmetry of the funnel plot and is not the cause of any
unexplained heterogeneity.
Limitations
The meta-analysis had a relatively small sample size which limited our options for
statistical analysis. There was statistical evidence of substantial heterogeneity. The
major source of the heterogeneity and funnel plot asymmetry was the inclusion of the
Etter, 2012 study. This study found a statistically insignificant decrease in impatience
after smoking cessation compared with the pre-cessation impatience score. Etter explains
that the unexpected result was attributed to the fact that it was an internet study which
may have caused a reactivity effect; i.e. repeated self-measures may modify symptoms
and behaviors. A meta-analysis excluding this study resulted in an increase in the
estimate and the heterogeneity was reduced to statistical non-significance. It is this
author’s belief that the Etter, 2012 study was an outlier and is inconsistent with other
impulsivity research outcomes.
The meta-analysis had some “unclear risk” of selection bias. The Cochrane Collaboration
tool for assessing risk of bias of randomized trials sets a high bar. Few published studies
report or make available the necessary information to objectively assess the risk of bias
for all categories of interest. This was especially true for this meta-analysis, few studies
discussed allocation concealment which refers to “techniques used to implement the
allocation sequence, not to generate it” (Higgins, Altman, Gotzche, & Juni, 2011).
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In general, high risk of bias was not an issue for this meta-analysis, even though Heil
2006 was not a randomized trial and Etter, 2012 had substantial loss to follow up, which
according to its author is common for internet studies.

Lastly, the meta-analysis could not address “offset effects” because that distinction was
not discussed in the included studies.

Conclusion

The meta-analysis shows that impulsivity increases post smoking cessation. These
findings imply that smoking cessation may have an effect on decision making.
Additionally higher rates of impulsivity have been associated with smoking relapse.
(Doran, Spring, McChargue, Peradia, & Richmond, 2004). In order to assist better in the
development of individual treatments, a better understanding is needed of how increased
impulsivity influences cognitive behavior and relapse rates. These findings support the
inclusion of impulsivity as a criterion for nicotine withdrawal.

43

APPENDIX
Meta-Analysis of Studies Investigation of the Effect of Smoking Cessation
Impatience Performed Using Excel 2010
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Events

Sample size
65
27
50
91
78
20
95
es
-0.12
0.32
0.60
0.60
0.67
0.30
0.68

SDDif f (r=.6)
0.82
0.83
0.70
1.08
0.80
0.67
0.54

SED
0.10
0.16
0.10
0.11
0.09
0.15
0.06

VarD
0.01
0.03
0.01
0.01
0.01
0.02
0.00

5.74

Study
Etter, Jean-Francois
Heil, Sarah
Hughes, John (1986)
Hughes, John (1991)
Jorenby, Douglas
Ussher, Michael Preg
Ussher, Michael non-Preg

7
6

-4.62

Sums:

k
df

I 2v

0.44
0.11
0.22
Random Effects
MV
VMv
SEMv
LLMv
ULMv
ZM

es(random)
SEes(random)
CI (random)

Qv

0.59

89.15
0.53
0.04
0.46

0.44
0.01
0.11
0.22
0.67
3.87

55.32

es(fixed) effect summary(
SEes(fixed)
CI (fixed)

0.53
0.00
0.04
0.46
0.59
14.99
55.32
624.65

Q
I2

Fixed Effect
M (weighted Mean)
variance of summary effe
SEM
LLM
ULM
Z
Q
C

1.46
3.98
36.73
28.09
55.40
4.00
150.29

153279.30

9,215.00
1,550.79
10,412.33
6,086.78
15,230.73
1,975.31
108,808.35

76.48

wv
11.19
9.58
11.27
10.90
11.49
9.86
12.20

w2
w*es
-11.84
12.52
61.22
46.81
82.69
13.33
222.66

279.96

w*(es 2)
w
95.99
39.38
102.04
78.02
123.41
44.44
329.86

427.39

Tau2

813.15

0.67

20.72

wv *es
wv *(es 2)
-1.38
0.17
3.05
0.97
6.76
4.06
6.54
3.92
7.70
5.16
2.96
0.89
8.23
5.56

840.66

wv 2
125.21
91.85
126.96
118.75
131.96
97.16
148.79

33.85
0.078951
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